Log in
Enquire now

List of PACT Pharma patents

List of PACT Pharma patents
List of Crinetics Pharmaceuticals patents
List of Skyhawk Therapeutics patents
List of AbbVie Inc. patents
List of companies in Unilazer Ventures's investment portfolio
List of Poynt patents
Patents where
Current Assignee
Name
is
PACT PharmaPACT Pharma
Name
Description
Patent Applicant
Current Assignee
Inventor
Patent Jurisdiction
Patent Number
Date of Patent
‌
US Patent 11513113 Compositions and methods for identification of antigen specific T cells

Patent 11513113 was granted and assigned to PACT Pharma on November, 2022 by the United States Patent and Trademark Office.

PACT Pharma
PACT Pharma
PACT Pharma
PACT Pharma
United States Patent and Trademark Office
United States Patent and Trademark Office
11513113
November 29, 2022
‌
US Patent 11304978 Compositions and methods for the treatment of cancer using a CD8 engineered T cell therapy

PACT Pharma
PACT Pharma
PACT Pharma
PACT Pharma
United States Patent and Trademark Office
United States Patent and Trademark Office
11304978
April 19, 2022
‌
US Patent 10711283 Primary cell gene editing

PACT Pharma
PACT Pharma
PACT Pharma
PACT Pharma
United States Patent and Trademark Office
United States Patent and Trademark Office
10711283
July 14, 2020
‌
US Patent 10550406 Primary cell gene editing

Patent 10550406 was granted and assigned to PACT Pharma on February, 2020 by the United States Patent and Trademark Office.

PACT Pharma
PACT Pharma
PACT Pharma
PACT Pharma
United States Patent and Trademark Office
United States Patent and Trademark Office
10550406
February 4, 2020
‌
US Patent 10875905 Peptide-MHC compacts

PACT Pharma
PACT Pharma
PACT Pharma
PACT Pharma
United States Patent and Trademark Office
United States Patent and Trademark Office
10875905
December 29, 2020
‌
US Patent 10676758 Primary cell gene editing

PACT Pharma
PACT Pharma
PACT Pharma
PACT Pharma
United States Patent and Trademark Office
United States Patent and Trademark Office
10676758
June 9, 2020
‌
US Patent 10584357 Primary cell gene editing

Patent 10584357 was granted and assigned to PACT Pharma on March, 2020 by the United States Patent and Trademark Office.

PACT Pharma
PACT Pharma
PACT Pharma
PACT Pharma
United States Patent and Trademark Office
United States Patent and Trademark Office
10584357
March 10, 2020
7 results
0 selected
7 results
0 selected
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us